1h Free Analyst Time
The publisher has been monitoring the structural heart devices market and it is poised to grow by $ 7.60 bn during 2022-2026, progressing at a CAGR of 10.03% during the forecast period. This report on the structural heart devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of structural heart diseases, regulatory approvals of new and advanced structural heart devices, and rising awareness about structural heart diseases in developing countries.
The structural heart devices market analysis included the method segment and geographic landscape.
The structural heart devices market is segmented as below:
By Method
- Replacement procedures
- Repair procedures
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies technological innovations in structural heart disease treatment as one of the prime reasons driving the structural heart devices market growth during the next few years. Also, the increasing number of partnerships and collaborations and the emergence of tissue-engineered heart valves will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on structural heart devices market covers the following areas:
- Structural heart devices market sizing
- Structural heart devices market forecast
- Structural heart devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading structural heart devices market vendors that include Abbott Laboratories, AFFLUENT MEDICAL SA, Artivion Inc., AtriCure Inc., Boston Scientific Corp., Braile Biomedica, CORONEO Inc., Edwards Lifesciences Corp., Getinge AB, Jc Medical Inc., Johnson and Johnson Inc., Lepu Medical Technology Beijing Co. Ltd., Lifetech Scientific Shenzhen Co. Ltd., LivaNova Plc, Medtronic Plc, Micro Interventional Devices Inc., NuMED Inc., Terumo Corp., TTK Healthcare Ltd., and W. L. Gore and Associates Inc. Also, the structural heart devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Method
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The Publisher Announces the Publication of its Research Report - Global Structural Heart Devices Market 2022-2026The publisher recognizes the following companies as the key players in the global structural heart devices market: Abbott Laboratories, AFFLUENT MEDICAL SA, Artivion Inc., AtriCure Inc., Boston Scientific Corp., Braile Biomedica, CORONEO Inc., Edwards Lifesciences Corp., Getinge AB, Jc Medical Inc., Johnson and Johnson Inc., Lepu Medical Technology Beijing Co. Ltd., Lifetech Scientific Shenzhen Co. Ltd., LivaNova Plc, Medtronic Plc, Micro Interventional Devices Inc., NuMED Inc., Terumo Corp., TTK Healthcare Ltd., and W. L. Gore and Associates Inc.
Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is technological innovations in structural heart disease treatment.'
According to the report, one of the major drivers for this market is the increasing prevalence of structural heart diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AFFLUENT MEDICAL SA
- Artivion Inc.
- AtriCure Inc.
- Boston Scientific Corp.
- Braile Biomedica
- CORONEO Inc.
- Edwards Lifesciences Corp.
- Getinge AB
- Jc Medical Inc.
- Johnson and Johnson Inc.
- Lepu Medical Technology Beijing Co. Ltd.
- Lifetech Scientific Shenzhen Co. Ltd.
- LivaNova Plc
- Medtronic Plc
- Micro Interventional Devices Inc.
- NuMED Inc.
- Terumo Corp.
- TTK Healthcare Ltd.
- W. L. Gore and Associates Inc.
